Skip to main content
Clinical Trials/NCT06830980
NCT06830980CompletedNot Applicable

TMS (Transcranial Magnetic Stimulation) for Methamphetamine Use Disorder in People Living With HIV

Gopalkumar Rakesh2 sites in 1 country12 target enrollmentStarted: March 11, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
12
Locations
2
Primary Endpoint
Cue-induced methamphetamine craving

Study Overview

Brief Summary

The purpose of this study is to learn more about how accelerated theta burst stimulation affects methamphetamine craving and brain activity. Theta burst stimulation is a unique transcranial magnetic stimulation (TMS) paradigm that is efficient and potent.

Detailed Description

The investigators will compare how two theta burst paradigms, intermittent theta burst stimulation (iTBS) and continuous theta burst stimulation (cTBS), compare with sham TMS in changing methamphetamine craving and brain activity. iTBS, cTBS, and sham TMS will be delivered in an accelerated fashion (two sessions daily, separated by 50 minutes). iTBS will be delivered to the left dorsolateral prefrontal cortex (left dorsolateral prefrontal cortex), and cTBS will be delivered to the frontal pole. A brain MRI scan will be done before and after the iTBS/cTBS/sham TMS sessions. The study involves four visits. Each visit will last three hours. Hence, participants will spend a total of 12 hours in the study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults in the age group 18-65 years
  • •Able to read and understand English
  • •Able to provide informed consent
  • •Diagnosed with HIV
  • •History of current or previous Methamphetamine Use Disorder
  • •Endorse craving for methamphetamine
  • •Demonstrate an attentional bias for methamphetamine

Exclusion Criteria

  • •Traumatic brain injury
  • •h/o seizure disorder
  • •h/o or current diagnosis of schizophrenia
  • •intracranial metal shrapnel
  • •previous adverse effects with TMS
  • •sub-threshold consistency while performing behavioral tasks
  • •lack of attentional bias to methamphetamine cues
  • •a positive pregnancy test for female participants
  • •abnormal brain MRI

Arms & Interventions

Group 1

Other

Group 1 will receive actual TMS (iTBS and cTBS) on days 2 and 3 and sham TMS on day 4.

Intervention: Sham TMS (Device)

Group 2

Other

Group 2 will receive actual TMS (iTBS and cTBS) on days 2 and 4 and sham TMS on day 3.

Intervention: intermittent theta burst stimulation (iTBS) (Device)

Group 2

Other

Group 2 will receive actual TMS (iTBS and cTBS) on days 2 and 4 and sham TMS on day 3.

Intervention: Sham TMS (Device)

Group 3

Other

Group 3 will receive sham TMS on day 2 and actual TMS (iTBS and cTBS) on days 3 and 4.

Intervention: intermittent theta burst stimulation (iTBS) (Device)

Group 3

Other

Group 3 will receive sham TMS on day 2 and actual TMS (iTBS and cTBS) on days 3 and 4.

Intervention: continuous theta burst stimulation (cTBS) (Device)

Group 3

Other

Group 3 will receive sham TMS on day 2 and actual TMS (iTBS and cTBS) on days 3 and 4.

Intervention: Sham TMS (Device)

Group 1

Other

Group 1 will receive actual TMS (iTBS and cTBS) on days 2 and 3 and sham TMS on day 4.

Intervention: intermittent theta burst stimulation (iTBS) (Device)

Group 1

Other

Group 1 will receive actual TMS (iTBS and cTBS) on days 2 and 3 and sham TMS on day 4.

Intervention: continuous theta burst stimulation (cTBS) (Device)

Group 2

Other

Group 2 will receive actual TMS (iTBS and cTBS) on days 2 and 4 and sham TMS on day 3.

Intervention: continuous theta burst stimulation (cTBS) (Device)

Outcomes

Primary Outcomes

Cue-induced methamphetamine craving

Time Frame: Baseline and before and after each TMS session up to 4 days

Measured on the visual analog scale (VAS) Scored 0 to 100 with 0=no craving and 100=the most craving.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Gopalkumar Rakesh
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Gopalkumar Rakesh

Assistant Professor

University of Kentucky

Study Sites (2)

Loading locations...

Similar Trials